Valentina Garibotto retweeted
today! 👇
Join us for our fifth talk in the Molecular Connectivity Online Series. This month's speaker is @JoanaBPereira1
Date: May 17, 15h CEST, 9h EDT, 21h CST
Register here: tum-conf.zoom.us/meeting/reg…
#MCOS #molecularconnectivity #MCWG
Valentina Garibotto retweeted
Mardi 21 mai, le Centre de recherche clinique vous convie au colloque "Implication des patients dans la recherche et la formation - Expérience lyonnaise", présenté par la Pre @JulieHaeseb. Plus d’infos 👉 hug.ch/evenement/crc/implica… #recherche #formation #santé
Valentina Garibotto retweeted
Future directions of tau PET for clinical use
In 2022, @OskarHansson9 and I identified the following knowledge gaps for optimal use of Tau PET in the clinic. Many of these still remain unaddressed.
Link > alz-journals.onlinelibrary.w…
Valentina Garibotto retweeted
Cerebrospinal fluid proteomics in people with Alzheimer disease reveals five molecular subtypes with distinct genetic risk profiles nature.com/articles/s43587-0…
Valentina Garibotto retweeted
Science Behind the Study: Sounding Out the Blood–Brain Barrier nej.md/41Jxg2V
Valentina Garibotto retweeted
Very happy to share our new work in @JAMANeuro, showing that ApoE4 triggers earlier and faster amyloid-related tau spreading. Thus, Anti-amyloid therapies may need to come earlier in E4 carriers to prevent tau. Huge thanks to @AnnaSteward_ and my team!
doi.org/10.1001/jamaneurol.2…
Valentina Garibotto retweeted
Highly recommended job opportunity!
We are looking for a highly motivated #postdoc to join our team for an exciting collaborative project on #AI image analysis. The position entails working closely with academic and industry partners in Sweden, the US, the UK and Germany.
Please share!
web103.reachmee.com/ext/I005…
Valentina Garibotto retweeted
Super happy to share our new work out in @NatureComms, showing that synaptic changes accelerate amyloid-related tau accumulation and spread in #Alzheimer's disease. Many thanks to @_michael_scholl and many others!
@ISD_Research, @goteborgsuni
doi.org/10.1038/s41467-023-4…
Valentina Garibotto retweeted
In a round-robin of plasma p-tau tests, p-tau217 came out on top. Two cut points might be needed to implement blood-based markers of #alzheimer’sdisease in the clinic. @lunduniversity @goteborgsuni @wustl alzforum.org/news/conference…
Valentina Garibotto retweeted
🔎🧠
Un #diagnosticprecoce d’#Alzheimer est utile et possible, selon une étude sur 840 personnes, coordonnée par les Hôpitaux universitaires de Genève.
Avec la participation de @VGaribotto
Pour en savoir plus👇
revue-horizons.ch/2023/09/07…
Valentina Garibotto retweeted
🔎🧠
A study with 840 participants has shown that diagnosing Alzheimer’s early makes sense and is possible, says Valentina Garibotto @VGaribotto of the Geneva University Hospitals.
See here for more information👇
horizons-mag.ch/2023/09/07/e…
Valentina Garibotto retweeted
Impressive work by the IDEAS team, successfully quantifying over 10.000 (!!!😳) 'real world' amyloid PET scans and showing high agreement with Centiloid quantification @CTADconference @RabLab_UCSF @relajoie
Valentina Garibotto retweeted
Kelly et al. compare cortical developmental trajectories in children born at term versus very preterm, and show that the impact of very preterm birth on cortical growth is amplified from infancy to adolescence. tinyurl.com/262mxyxx
Valentina Garibotto retweeted
A real honour and a testament to the collective efforts of our world-class team @PeterMacCC This accolade strengthens our commitment to advancing nuclear medicine, improving patient outcomes & continuing our journey of innovative healthcare solutions in Australia and beyond. – at Brisbane, Queensland
Pioneering new imaging technologies for cancer – a nuclear medicine physician‐scientist, his technologies are more accurate than standard imaging, with better outcomes compared to chemotherapy. Welcome Prof @DrMHofman as a new #AAHMSFellow.
@PeterMacCC @Pros_TIC
Valentina Garibotto retweeted
Get to know EANM #EUProjects - #RLTAcademy
🇪🇺Building the Radioligand Therapy Academy
📝Unique EU-level training opportunity in which EANM is co-shaping the academy with partners, mainly focusing on developing training curricula & material on RLT.
👉bit.ly/3LYAQQj
Valentina Garibotto retweeted
Exciting opportunity!📢
The EANM team is growing and is currently seeking a part-time Communications Officer to join our Communications Team.
📆Application deadline: November 27, 2023.
🔗eanm.org/about/careers/
Valentina Garibotto retweeted
Day 4 of #NMW23 is about hearing the voices of our patients. SNMMI TV sits down with Alan Held, who was diagnosed with prostate cancer, received his PSMA treatment in Germany, and is now cancer-free. He dives deep into his experience: ow.ly/7qb350PQLx0
Valentina Garibotto retweeted
Using PSMA for Response Assessment at 3 months of ARPI avoids flair and predicts OS. Check our results just published on @JournalofNucMed. Prospective validation urgently needed. doi.org/10.2967/jnumed.123.2…
Great job by our PhD fellow @q_shagera @JulesBordet
Valentina Garibotto retweeted
Allier chimie et biologie pour détecter une maladie, suivre son évolution ou mettre en place des traitements ciblés : c’est le rôle du Service de #médecine nucléaire et d’imagerie moléculaire, dont la Pre @VGaribotto est responsable #nucléaire #imagerie pulsations.hug.ch/article/la…
Valentina Garibotto retweeted
Congrats to @jpfsouza33, @TharickAPascoal and team on their new paper providing evidence of APOE4 potentiating amyloid-beta's effect on tau accumulation
nature.com/articles/s43587-0…

































